with infection. A composite risk score was created using retained factors in stepwise multivariable logistic regression modeling.
INTRODUCTION AND OBJECTIVES: Bacterial adhesion and biofilm formation on urological devices such as stents and catheters is an undesirable phenomena that can lead to device-related infection and other co-morbidities. A range of potential technologies utilizing both passive mechanisms and active antimicrobials have been developed to combat this issue, but clinical efficacy remains limited. The objective of this study was to investigate the ability of a novel passive surface modification technology using fluorinated surface modifying molecules (SMMs) to address this clinical need.
METHODS: Polyurethane control and SMM-modified prototypes for testing (rods or catheter tubing) were prepared using standard melt extrusion processes. X-ray photoelectron spectroscopy confirmed the presence of SMMs at device surfaces. Efficacy of devices to resist bacterial adhesion was assessed using both static and flow models. Static experiments consisted of sample incubation in bacterial inoculum followed by sonication to detach adhered bacteria and quantification by plate counts. Flow experiments were conducted using a custom circulating flow system with artificial urine.
RESULTS: SMM-modified prototypes showed up to 2 log lower microbial adhesion compared to unmodified controls after 2h incubation in buffer inoculated with various gram positive, gram negative bacteria or yeast. The anti-adhesive property of SMM prototypes was confirmed in both artificial and human urine with three uropathogens (Escherichia coli, Enterococcus faecalis, Proteus mirabilis), as well as in clinical urine samples from patients with ureteral stents, where SMM-modified samples showed reduced attachment of mixed bacterial populations after 24h of incubation. Experiments under flow demonstrated potential of SMM-modified surfaces to resist adhesion in dynamic environments and for extended time frames, with 5 log lower attachment of E. coli observed on SMM-modified tubing vs controls at both 1 and 3 days post inoculation. Corresponding reductions in biofilm formation were confirmed with crystal violet staining and scanning electron microscopy.
CONCLUSIONS: Modification of urological devices with SMMs may be an effective strategy to reduce bacterial adhesion and biofilm formation. The passive nature of the SMMs is advantageous as it provides a stable surface not subject to depletion or de-activation of the functional entity over time, as may be the case for surfaces modified with eluting or active antimicrobials.
Source of Funding: Mitacs Accelerate Postdoctoral Fellowship
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THE DIAGNOSTIC VALUES OF SYMPTOMS FOR ACUTE UNCOMPLICATED CYSTITIS e EVALUATION OF THE PROPOSED UPDATED FDA GUIDELINES Jakhongir Alidjanov*, Gießen, Germany; Kurt Naber, Straubing, Germany; Adrian Pilatz, Gießen, Germany; Ulugbek Abdufattaev, Tashkent, Uzbekistan; Florian Wagenlehner, Gießen, Germany INTRODUCTION AND OBJECTIVES: Recently, US Food and Drug Administration (FDA) has proposed to use at least two of the four following symptoms for diagnosis of acute uncomplicated cystitis (AC) in women: dysuria, urinary frequency, urinary urgency, and suprapubic pain. We aimed to reevaluate the diagnostic values of symptoms for AC, using the Acute Cystitis Symptom Score (ACSS), having been validated in several languages.
METHODS: The data derived from the ACSS database were analyzed and used for validating the updated FDA guidelines. Different diagnostic values of the signs, symptoms and their severity were assessed. «Model fit» analysis of the linear models and 2x2 contingency tables were used for basic statistical analysis.
RESULTS: Of the 911 respondents from 7 different countries, 872 (median for age ) were selected for the analysis. Respondents were allocated to groups of Patients (n[453) and Controls (n[418) according to the diagnosis of a physician concerning the presence or absence of AC, based on physical and laboratory findings. The accuracy of the diagnosis increased significantly for all symptoms when the severity of a symptom was included in the analysis. Highest diagnostic values were shown by dysuria in the «model fit» and odds ratio analyses, both for the presence and severity of this symptom. Urinary frequency and visible blood in the urine had no significant association with the diagnosis of AC when the analysis was based only on the presence or absence of signs. Inclusion the severity of urinary frequency into the analysis increased the strength of its association with AC up to significant values. The diagnostic values of suprapubic pain and sense of incomplete bladder emptying were about the same and had a significant positive association with AC. The inclusion of the severity into the analysis decreased the association of suprapubic pain with AC to insignificant values.
CONCLUSIONS: The severity of the symptoms rather than their presence itself is essential for an accurate diagnosis of AC. Dysuria has the highest diagnostic value of the typical symptoms. In addition to the four symptoms proposed by the FDA, we propose also to include a sense of incomplete bladder emptying into the list of additional symptoms for the diagnosis of AC. It is, however, necessary to consider the INTRODUCTION AND OBJECTIVES: Characterizing women's perceptions of urinary tract infections (UTI) helps patients achieve a better understanding of their disease and increases the likelihood of treatment success. Focus groups, interviews, and surveys are designed by providers and limited by their sample size. Online-community research allows for an enormous, international and unbiased sample, allowing researchers to hear authentic patient experiences. Analyzing thousands of posts, we identified shared emotions, prevention strategies, alternative therapies, and knowledge gaps regarding UTIs.
METHODS: We collected 83,572 posts from 863 websites used internationally by collaborating with Treato, a social media data mining service, which combines search terms with Java-based natural language processing. From the randomized dataset, 200 posts were qualitatively analyzed using grounded theory to identify preliminary themes. To complement the qualitative analysis and validate a new computational technique, we concurrently applied Latent Dirichlet Allocation (LDA) probabilistic topic modeling to the full dataset for theme discovery in the entirety of the posts.
RESULTS: Seven preliminary themes with sub-themes were identified. Users trust online communities and posts are not subject to the Hawthorne effect. Online forums share a dynamic source of information and encouragement as peers validate symptoms and feelings and advise on treatments. The diversity of posts reflects the breadth of variation in UTIs from symptoms to therapies. Regarding recurrent UTIs especially, women are frustrated and feel unheard by their providers, turning to homeopathy for possibilities. There is much information shared on behavior modification for prevention: post-coital practices, hydration, and hygiene. Women share experiences with various antibiotics and discuss diagnostic tests. There is a strong understanding of complications of untreated UTIs and fear surrounding lack of treatment. Barriers to accessing care and confusion about care permeate in many posts. There is a desire for knowledge acquisition in all aspects CONCLUSIONS: In social media networks, patients feel supported online, users validate feelings and confirm symptoms. Providers can use this data to identify common misconceptions and improve knowledgesharing with patients leading to improved patient satisfaction and better care through optimal communication and genuine shared-decision making. 
MP71-12 THE CLINICAL RATE OF ANTIBIOTIC CHANGE FOLLOWING EMPIRIC TREATMENT FOR SUSPECTED URINARY TRACT INFECTIONS
Jonathan Dokter, Rochester, MI; Laura Nguyen, Lauren Tennyson*, Esther Han, Larry T Sirls, Royal Oak, MI INTRODUCTION AND OBJECTIVES: When treating urinary tract infection (UTI) urine culture delay forces clinicians to decide whether to start empiric antibiotics, possibly incorrectly. We evaluated empiric antibiotic use and subsequent change in a FPMRS practice.
METHODS: Patients with suspected UTI and urine culture from Jan 2016 to June 2016 were retrospectively reviewed. Exclusion criteria included indwelling catheter, institutionalized, recent urologic surgery, pregnancy, and urinary diversion. Patients with a positive culture (defined as > 10 3 CFU) were categorized by whether or not they were treated empirically. Empiric treatment was evaluated for associations with clinical-demographic data, symptoms and urinalysis (UA). Antibiotic change was evaluated with clinical-demographic data, urine culture results and resistance patterns. Statistical significance of differences between groups was assessed with chi-square or Fisher's exact test for categorical variables and t-test for continuous measures.
RESULTS: 916 urine cultures (636 patients) were included. 391 (43%) cultures were positive, and 164 (42%) were treated empirically. Demographics including age, gender, BMI, history of diabetes, or immunosuppression did not differ between groups. Those treated empirically had more UTI symptoms (93% vs 58% P < 0.001), and UA abnormalities including positive nitrites (51% vs 29% P < 0.001), 3þ leukocyte esterase (27% vs 19% P [ 0.002) and 3þ blood (13% vs 4% P [ 0.005). The most common bacteria in both groups were E. coli, followed by Klebsiella and Enterococcus. The most common empiric treatments were Macrobid (24%), TMP-SMX (22%), ciprofloxacin (15%) and doxycycline (13%). Of those treated empirically, 42/164 (26%) required an antibiotic change. Antibiotic change was associated with immunosuppression (12% vs 2% P [ 0.027) and > 3 antibiotic resistance (33% vs. 20%, P [ 0.039). Patients requiring empiric antibiotic change also had higher rates of fluoroquinolone (50% vs 30% P [ 0.016), monobactam (19% vs 7% P [ 0.042) and TMP-SMX (52% vs 19% P < 0.001) resistance.
CONCLUSIONS: Almost half of patients with clinical UTI were treated empirically. Factors associated with empiric treatment included symptoms and abnormal UA. Antibiotic change was driven largely by bacterial resistance. New technologies that allow rapid urine bacterial identification and sensitivities may greatly improve patient care. METHODS: Retrospective data on women (age > 18) with symptoms of an uncomplicated UTI, submitting urine cultures as outpatients in the Northwestern Healthcare System from 2011 to 2017 was gathered. Demographic and healthcare use data, diagnosis codes, UA and urine culture results were collected. Positive cultures (PC) were evaluated at 10 3 , 10 4 and 10 5 cfu/mL. Univariate and multivariable regression models determined likelihood ratios (LR) for predicting positive urine culture (10^4 cfu/mL).
RESULTS: In the 20,759 patients, 11,488 (55.3%), 10,451 (50.3%) and 6,996 (33.7%) had PCs based on 10^3, 10^4 and 10^5 cfu/ mL, respectively, and 6,958 (33.5%) had at least one prior culture. 
